Protective Genetic Variants for Alzheimer Disease in the Amish
阿米什人阿尔茨海默病的保护性遗传变异
基本信息
- 批准号:9439190
- 负责人:
- 金额:$ 753.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-15 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAllelesAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAmishAmyloid beta-ProteinArchitectureBiologicalBiologyCase-Control StudiesCell physiologyChromosomesCognitiveCollectionCommunitiesConsanguinityCoupledDNADataData LinkagesData SetDementiaDevelopmentDietEducational BackgroundEmotionalEnvironmental Risk FactorEtiologyFamilyFounder GenerationGene ExpressionGeneral PopulationGenerationsGenesGeneticGenetic Predisposition to DiseaseGenetic RiskGenetic TranscriptionGenetic VariationGenomicsGenotypeGoalsIn VitroInbreedingIndianaIndividualLife StyleMaintenanceMetabolismOhioOnset of illnessParentsPathway interactionsPhasePlayPopulationProcessPropertyQuality ControlResearchResearch DesignRiskRoleSNP genotypingSamplingScreening procedureSeriesSignal TransductionSurvival AnalysisTestingVariantVertebral columnWorkbasecandidate validationcase controlcognitive testingexomeexperimental studyfollow-upgenetic associationgenetic linkage analysisgenetic pedigreegenetic risk factorgenetic variantgenome sequencinggenomic datanoveloffspringoverexpressionphenotypic dataprotein expressionrare variantreference genomerisk variantscreeningsecondary analysissuccesstau Proteinstransmission processwhole genome
项目摘要
ABSTRACT:
Alzheimer disease (AD) is the most common form of dementia in older individuals. Both genetic and
environmental factors contribute to AD risk, yet despite huge research efforts, a significant portion of the genetic
etiology of AD remains unexplained. Population-wide studies of unrelated AD cases and controls have identified
several common genetic risk factors and through the Alzheimer’s Disease Sequencing Project (ADSP) whole
exome (WES) and whole genome sequencing (WGS) data are being analyzed to identify AD risk modulators.
However, the primary focus of almost all of these studies has been on identifying variants that increase risk;
studies designed to identify variants that may protect from AD are few and usually underpowered. Thus,
additional strategies are required to identify functional variants that protect against or delay the
development of AD. The Amish provide a powerful and unique opportunity to identify variants protecting against
AD whilst controlling for some confounding factors such as level of education, lifestyle and diet. In addition, the
large Amish pedigrees offer an enrichment strategy for identifying rare variants since Mendelian transmissions
from parents to offspring, coupled to inbreeding loops, maximize the chance that multiple copies of rare variants
exist. The primary goal of this project is to identify genetic variations offering protection against AD. The project
will achieve this goal by pursuing three specific aims: (1): Generation of a family-based Amish AD Protective
Variant dataset. We will collect DNA and phenotype data from Amish families in Ohio and Indiana by examining
and following 800 known and newly identified cognitively normal individuals age 80+ and their 1st and 2nd degree
relatives. We will perform SNP genotyping on all samples and WGS on a subset of 200 cognitively normal
individuals; (2): Identification of AD protective variants. Sibships with multiple individuals who are age 80+
and cognitively normal will be analyzed for genetic linkage, IBD segment sharing, and association. Single-marker
analyses will be supplemented by gene-wise analysis and pathway (gene set-based) analysis; (3): Perform
functional validation of candidate protective variants. These experiments will include screening for effects
on gene expression, impact on Aβ or tau processing, and effects on cellular function.
抽象的:
阿尔茨海默病 (AD) 是老年人中最常见的痴呆症,既有遗传性的,也有遗传性的。
环境因素会导致 AD 风险,尽管进行了大量的研究工作,但很大一部分遗传因素
AD 的病因仍然无法解释,对不相关的 AD 病例和对照进行的全人群研究已确定。
几个常见的遗传风险因素并通过阿尔茨海默病测序项目 (ADSP) 整体
正在分析外显子组 (WES) 和全基因组测序 (WGS) 数据,以确定 AD 风险调节剂。
然而,几乎所有这些研究的主要焦点都是识别增加风险的变异。
旨在识别可能预防 AD 的变异的研究很少,而且通常力度不够。
需要额外的策略来识别功能变体,以防止或延迟
阿米什人的发展提供了一个强大而独特的机会来识别预防变异。
AD 同时控制一些混杂因素,如教育水平、生活方式和饮食。
庞大的阿米什血统提供了一种丰富策略,用于识别自孟德尔传播以来的罕见变异
从父母到后代,再加上近亲繁殖循环,最大限度地提高了稀有变异的多个拷贝的机会
该项目的主要目标是识别可预防 AD 的遗传变异。
将通过追求三个具体目标来实现这一目标:(1):产生以家庭为基础的阿米什 AD 保护
我们将通过检查从俄亥俄州和印第安纳州的阿米什家庭收集 DNA 和表型数据。
并追踪了 800 名已知和新发现的 80 岁以上认知正常且一级和二级认知正常的个体
我们将对所有样本进行 SNP 基因分型,并对 200 名认知正常的样本进行全基因组测序 (WGS)。
个人;(2):与多个 80 岁以上个人的 AD 保护性变体的识别。
将分析认知正常的遗传连锁、IBD 片段共享和关联。
(3):执行
这些实验将包括筛选效应。
对基因表达、对 Aβ 或 tau 加工的影响以及对细胞功能的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan L Haines其他文献
Jonathan L Haines的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan L Haines', 18)}}的其他基金
Protective Genetic Variants for Alzheimer Disease in the Amish - RENEWAL
阿米什人阿尔茨海默病的保护性遗传变异 - RENEWAL
- 批准号:
10448612 - 财政年份:2022
- 资助金额:
$ 753.77万 - 项目类别:
Protective Genetic Variants for Alzheimer Disease in the Amish - RENEWAL
阿米什人阿尔茨海默病的保护性遗传变异 - RENEWAL
- 批准号:
10689703 - 财政年份:2022
- 资助金额:
$ 753.77万 - 项目类别:
Epidemiology of Biomarkers of AMD Progression
AMD 进展生物标志物的流行病学
- 批准号:
10489288 - 财政年份:2021
- 资助金额:
$ 753.77万 - 项目类别:
Protective Genetic Variants for Alzheimer Disease in the Amish
阿米什人阿尔茨海默病的保护性遗传变异
- 批准号:
9898659 - 财政年份:2017
- 资助金额:
$ 753.77万 - 项目类别:
Advancing Genetics Through the AMDgene Consortium
通过 AMDgene 联盟推进遗传学发展
- 批准号:
8265101 - 财政年份:2012
- 资助金额:
$ 753.77万 - 项目类别:
Advancing Genetics Through the AMDgene Consortium
通过 AMDgene 联盟推进遗传学发展
- 批准号:
8449079 - 财政年份:2012
- 资助金额:
$ 753.77万 - 项目类别:
Advancing Genetics Through the AMDgene Consortium
通过 AMDgene 联盟推进遗传学发展
- 批准号:
8655882 - 财政年份:2012
- 资助金额:
$ 753.77万 - 项目类别:
相似国自然基金
等位基因聚合网络模型的构建及其在叶片茸毛发育中的应用
- 批准号:32370714
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于人诱导多能干细胞技术研究突变等位基因特异性敲除治疗1型和2型长QT综合征
- 批准号:82300353
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠杆菌多粘菌素异质性耐药中phoPQ等位基因差异介导不同亚群共存的机制研究
- 批准号:82302575
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACR11A不同等位基因调控番茄低温胁迫的机理解析
- 批准号:32302535
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
玉米穗行数QTL克隆及优异等位基因型鉴定
- 批准号:
- 批准年份:2022
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Impact of Mitochondrial Lipidomic Dynamics and its Interaction with APOE Isoforms on Brain Aging and Alzheimers Disease
线粒体脂质组动力学及其与 APOE 亚型的相互作用对脑衰老和阿尔茨海默病的影响
- 批准号:
10645610 - 财政年份:2023
- 资助金额:
$ 753.77万 - 项目类别:
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 753.77万 - 项目类别:
Upregulation of progranulin in a human iPSC-derived neurovascular model of GRN-associated Frontotemporal Dementia
GRN 相关额颞叶痴呆的人 iPSC 衍生神经血管模型中颗粒体蛋白前体的上调
- 批准号:
10789724 - 财政年份:2023
- 资助金额:
$ 753.77万 - 项目类别:
Investigating the role of CSF production and circulation in aging and Alzheimer's disease
研究脑脊液产生和循环在衰老和阿尔茨海默病中的作用
- 批准号:
10717111 - 财政年份:2023
- 资助金额:
$ 753.77万 - 项目类别: